This page is part of the HL7 FHIR Implementation Guide: minimal Common Oncology Data Elements (mCODE) Release 1 - US Realm | STU1 (v4.0.0-ballot: STU4 Ballot 1) based on FHIR (HL7® FHIR® Standard) R4. The current version which supersedes this version is 3.0.0. For a full list of available versions, see the Directory of published versions
Official URL: http://hl7.org/fhir/us/mcode/ValueSet/mcode-histology-morphology-behavior-vs | Version: 4.0.0-ballot | |||
Active as of 2024-04-10 | Maturity Level: 4 | Computable Name: HistologyMorphologyBehaviorVS | ||
Other Identifiers: OID:2.16.840.1.113883.4.642.40.15.48.36 | ||||
Copyright/Legal: This value set includes content from SNOMED CT, which is copyright © 2002+ International Health Terminology Standards Development Organisation (IHTSDO), and distributed by agreement between IHTSDO and HL7. Implementer use of SNOMED CT is not covered by this agreement |
Codes representing the structure, arrangement, and behavioral characteristics of malignant neoplasms, and cancer cells. Inclusion criteria: in situ neoplasms and malignant neoplasms. Exclusion criteria: benign neoplasms and neoplasms of unspecified behavior. Note: ICD-O-3 morphology codes are referenced in the logical definition but not expanded in the value set for intellectual property reasons. For primary cancers, the ICD-O-3 behavior suffix should be /1, /2, or /3. For secondary cancers, the ICD-O-3 behavior suffix should be /6.
References
Changes since version true:
This value set includes codes based on the following rules:
http://terminology.hl7.org/CodeSystem/icd-o-3
http://snomed.info/sct
where concept is-a 367651003 (Malignant Neoplasm (Morphology))http://snomed.info/sct
where concept is-a 399919001 (Carcinoma in situ - category (morphologic abnormality))http://snomed.info/sct
where concept is-a 399983006 (In situ adenomatous neoplasm - category (morphologic abnormality))http://snomed.info/sct
Code | Display |
399878004 | Malignant neoplasm with pilar differentiation (morphologic abnormality) |
253035009 | In situ melanocytic morphology (morphologic abnormality) |
This value set excludes codes based on the following rules:
http://snomed.info/sct
where concept is-a 450893003 (Papillary neoplasm, pancreatobiliary-type, with high grade intraepithelial neoplasia (morphologic abnormality))http://snomed.info/sct
where concept is-a 128640002 (Prostatic intraepithelial neoplasia, grade III)http://snomed.info/sct
where concept is-a 450890000 (Glandular intraepithelial neoplasia, low grade)http://snomed.info/sct
where concept is-a 703548001 (Atypical hyperplasia of the endometrium)
Expansion based on code system fragment http://terminology.hl7.org/CodeSystem/icd-o-3 http://terminology.hl7.org/CodeSystem/icd-o-3 version 2000
Expansion based on:
This value set expansion contains 6 concepts.
Code | System | Display | Inactive |
8500/3 | http://terminology.hl7.org/CodeSystem/icd-o-3 | Infiltrating duct carcinoma, NOS | |
367651003 | http://snomed.info/sct | Malignant Neoplasm (Morphology) | inactive |
399919001 | http://snomed.info/sct | Carcinoma in situ - category (morphologic abnormality) | inactive |
399983006 | http://snomed.info/sct | In situ adenomatous neoplasm - category (morphologic abnormality) | inactive |
399878004 | http://snomed.info/sct | Malignant neoplasm with pilar differentiation (morphologic abnormality) | |
253035009 | http://snomed.info/sct | In situ melanocytic morphology |
Explanation of the columns that may appear on this page:
Level | A few code lists that FHIR defines are hierarchical - each code is assigned a level. In this scheme, some codes are under other codes, and imply that the code they are under also applies |
System | The source of the definition of the code (when the value set draws in codes defined elsewhere) |
Code | The code (used as the code in the resource instance) |
Display | The display (used in the display element of a Coding). If there is no display, implementers should not simply display the code, but map the concept into their application |
Definition | An explanation of the meaning of the concept |
Comments | Additional notes about how to use the code |